AUG 6, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Pravastatin Sodium (Manufacturing (CMC))
U.S. Food and Drug Administration
FDA supplemental approval for manufacturing changes to an established statin; documents regulatory authorization but does not report clinical efficacy or comparative outcome data.
Reported
Approval date2026-08-06
Application numberANDA077491